Genic Balance Sheet Health
Financial Health criteria checks 4/6
Genic has a total shareholder equity of ₩11.7B and total debt of ₩10.0B, which brings its debt-to-equity ratio to 85.3%. Its total assets and total liabilities are ₩29.1B and ₩17.4B respectively.
Key information
85.3%
Debt to equity ratio
₩10.00b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩3.76b |
| Equity | ₩11.72b |
| Total liabilities | ₩17.38b |
| Total assets | ₩29.10b |
Recent financial health updates
Genic (KOSDAQ:123330) Is Making Moderate Use Of Debt
Mar 19
We Think Genic (KOSDAQ:123330) Has A Fair Chunk Of Debt
Dec 03Recent updates
There's Reason For Concern Over Genic Co., Ltd.'s (KOSDAQ:123330) Massive 34% Price Jump
Oct 10Genic Co., Ltd.'s (KOSDAQ:123330) Share Price Not Quite Adding Up
Jul 27Genic Co., Ltd.'s (KOSDAQ:123330) Shareholders Might Be Looking For Exit
Mar 12Genic (KOSDAQ:123330) Is Making Moderate Use Of Debt
Mar 19We Think Genic (KOSDAQ:123330) Has A Fair Chunk Of Debt
Dec 03Financial Position Analysis
Short Term Liabilities: A123330's short term assets (₩16.1B) do not cover its short term liabilities (₩17.2B).
Long Term Liabilities: A123330's short term assets (₩16.1B) exceed its long term liabilities (₩161.1M).
Debt to Equity History and Analysis
Debt Level: A123330's net debt to equity ratio (53.2%) is considered high.
Reducing Debt: A123330's debt to equity ratio has reduced from 85.6% to 85.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A123330 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A123330 has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 46.9% each year.